ID: ALA4113812

Max Phase: Preclinical

Molecular Formula: C26H28F3N7O3

Molecular Weight: 543.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CCC[C@@H]1C(=O)N1CC[C@@H](OCCOc2ncc(-c3nc(C#N)nc4c3ccn4C)cc2C(F)(F)F)C1

Standard InChI:  InChI=1S/C26H28F3N7O3/c1-34-7-3-4-20(34)25(37)36-9-5-17(15-36)38-10-11-39-24-19(26(27,28)29)12-16(14-31-24)22-18-6-8-35(2)23(18)33-21(13-30)32-22/h6,8,12,14,17,20H,3-5,7,9-11,15H2,1-2H3/t17-,20-/m1/s1

Standard InChI Key:  AIGANYAHXYWHIY-YLJYHZDGSA-N

Associated Targets(Human)

CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ctss Cathepsin S (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 543.55Molecular Weight (Monoisotopic): 543.2206AlogP: 3.01#Rotatable Bonds: 7
Polar Surface Area: 109.40Molecular Species: NEUTRALHBA: 9HBD: 0
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.95CX LogP: 3.02CX LogD: 2.36
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.42Np Likeness Score: -1.18

References

1.  (2016)  Nitrogen-containing bicyclic aromatic heterocyclic compound, 

Source

Source(1):